PAXX and breast carcinoma: Consistently, analysis of the TCGA breast cancer database also demonstrated that C9orf142 was upregulated in TNBC samples, and its expression levels in TNBC were slightly higher than that in luminal and HER2‐positive subtypes of breast cancer (Figure S1E).